Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Net Income towards Common Stockholders (2016 - 2025)

ENDRA Life Sciences has reported Net Income towards Common Stockholders over the past 6 years, most recently at -$3.1 million for Q4 2021.

  • Quarterly Net Income towards Common Stockholders fell 37.94% to -$3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$11.4 million through Dec 2021, up 6.34% year-over-year, with the annual reading at -$7.0 million for FY2025, 38.93% up from the prior year.
  • Net Income towards Common Stockholders was -$3.1 million for Q4 2021 at ENDRA Life Sciences, down from -$2.7 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at -$741623.0 in Q1 2017 and troughed at -$9.0 million in Q4 2019.
  • The 5-year median for Net Income towards Common Stockholders is -$2.7 million (2019), against an average of -$2.8 million.
  • Year-over-year, Net Income towards Common Stockholders crashed 281.68% in 2019 and then surged 75.07% in 2020.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$2.3 million in 2017, then decreased by 3.09% to -$2.4 million in 2018, then crashed by 281.68% to -$9.0 million in 2019, then surged by 75.07% to -$2.3 million in 2020, then tumbled by 37.94% to -$3.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Net Income towards Common Stockholders are -$3.1 million (Q4 2021), -$2.7 million (Q3 2021), and -$3.2 million (Q2 2021).